Abstract
Background Chronic pain conditions are complex multifactorial disorders with physical, psychological, and environmental factors contributing to their onset and persistence. Among these conditions, the role of brain-derived neurotrophic factor (BDNF) and the impact of a specific therapeutic education (TE) on pain management have emerged as important areas of research.
Objective The aim of this study is to investigate the effects of a specific type of therapeutic education on pain levels and BDNF concentrations.
Methods In this single-blind, randomized clinical trial, patients will be randomly assigned to one of two groups: one group will receive education with TE and the other group will receive education without TE. Assessments will be made at baseline, mid-treatment, post-intervention, and at one and eight months.
Outcomes The expected results of this study will shed light on the role of TE in pain management and provide insight into its effects on BDNF levels. The intervention will also provide an opportunity to biochemically measure the plastic changes, thereby improving our understanding of its effects on brain plasticity.
Conclusion This study aims to determine the applicability of therapeutic education as an effective non-pharmacological intervention for the management of chronic pain. The rigorous scientific methods used ensure that the proposed interventions will be clinically applicable across different health care systems.
The study will use a specifically pain oriented methodological approach that intends to go beyond purely informational pain neuroscience education, aiming for a more useful understanding of pain from patients.
Incorporating the salutogenic model in therapeutic education will bring a health focused perspective to the research, potentially enriching its interpretive framework helping future interventions.
The proposed use of clear and replicable guidelines such as GREET or TIDieR may help in the practical implementation challenge for clinicians, potentially influencing also the study’s reproducibility.
While the study plans to assess psychosocial factors, pain intensity levels, and brain plastic changes due to therapeutic education, this comprehensive approach might pose notable methodological challenges.
Given the emerging field of brain plasticity related to therapeutic education in chronic pain patients, the limited existing research may influence the interpretive depth of the study’s findings.
Protocol version In this first version of the protocol dated July 2023, we are recruiting the sample, which is planned to be completed in approximately two months (September 2023) in order to start the trial in October 2023.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT05623579
Funding Statement
The authors received financial support for the future randomized clinical trial from the CSEU La SALLE (Universidad Autónoma de Madrid) with grant number: 2022A36005 but not for this protocol. The authors who have received funding are not part of the present study as it is a shared project.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical committee registration number: 1901202202822. (Rey Juan Carlos University)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Sponsor contact information: Raúl Ferrer Peña raul.ferrer{at}lasallecampus.es
Sponsor and funder: CSEU La Salle (UAM), Madrid.
Committees: Rey Juan Carlos University Ethical Committee.
Data Availability
No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion
List of acronyms
- BDNF
- Brain Derived Neurotrophic Factor
- CERT
- Consensus on Exercise Reporting Template
- CP
- Chronic Pain
- CPGS
- Chronic Pain Grading Scale
- CPSS
- Chronic Pain Self-Efficacy Scale
- ECD
- Pain catastrophizing scale
- EQ-5D
- EuroQol-5 Dimensions
- GREET
- Guideline for Reporting Evidence-based practice Educational interventions and Teaching
- HADS
- Hospital Anxiety and Depression Scale
- HR
- Heart Rate
- IPAQ
- International Physical Activity Questionnaire
- PICO
- Population, Intervention, Control, Outcomes
- PPT
- Pressure Pain Threshold
- POBTE
- Pain Oriented Biobehavioral Therapeutic Education
- PSQI
- Pittsburgh Sleep Quality Index
- PSS
- Perceived Stress Scale
- REC
- Research Ethic Committee
- RCT
- Randomized Controlled Trial
- SPIRIT
- Standard Protocol Items: Recommendations for Interventional Trial
- TE
- Therapeutic Education
- TIDieR
- Template for Intervention Description and Replication
- TP
- Total Plasma
- TSK
- Tampa Scale for Kinesiophobia
- VAS
- Visual Analogue Scale
